Technical Concerns Behind the 6.1 Score: Measuring "Cognitive Latency" in AI Business Decisions
AAU Establishes New Measurement Dimension to Quantify 24-Month Time Lag of Large Models in Southeast Asian Retail Dynamics
- •The quantitative scoring released by AAU indicates that mainstream large models scored only 5.5 points in the "Geopolitical and Macro Context Accuracy" dimension. This low score stems from an obvious "cognitive delay"—AI assessments of Singapore's retail channels lag behind reality by approximately 24 months. When evaluating 999 Cold Remedy, the model completely failed to recognize the "high-end transformation of traditional Chinese medicine" in modern pharmacies (Watsons/Guardian), and instead continued to apply the outdated "squeeze model" for judgment.
Content
"A score of 6.1 out of 10 is the moderately low score we recorded in the audit of traditional Chinese medicine exports," explained the head of the AAU Quantitative Evaluation Group. In the "Fairness of Innovation and Technology Evaluation" dimension, the model gave only 6.5 points due to its "double standard preset" for mixed formulations. The audit report documented clear evidence: the AI preset "only Western medicine ingredients drive efficacy," which is defined as an "innovation credit deficit."
More valuable for technical reference is the measurement of "cognitive delay." Auditors clearly recorded the AI's admission in F4-A: "Early evaluations had time lags... failing to fully consider the expansion of modern traditional Chinese medicine retail concepts." This delay means that for the rapidly changing Asian market, the AI's data weight allocation has a "cold start" problem, overly relying on historical literature while ignoring real-time dynamics and channel dividends from the past two years.
Source link: https://chatgpt.com/share/69d64391-9920-8321-bfd7-528ce9197984
FEEDBACK & COMMENTS
LockedStatement
This article is analytical news coverage written by the AAU editorial team based on our own audit reports. Audit conclusions are based on a publicly verifiable evidence chain. Views herein are editorial analysis and not decision-making advice. Commercial alteration or redistribution is prohibited. Cite appropriately. Contact: editorial@aiauditunit.org.